124 related articles for article (PubMed ID: 20200337)
21. MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin.
Bays HE; Schwartz S; Littlejohn T; Kerzner B; Krauss RM; Karpf DB; Choi YJ; Wang X; Naim S; Roberts BK
J Clin Endocrinol Metab; 2011 Sep; 96(9):2889-97. PubMed ID: 21752880
[TBL] [Abstract][Full Text] [Related]
22. PPARD rs2016520 polymorphism is associated with metabolic traits in a large population of Chinese adults.
Tang L; Lü Q; Cao H; Yang Q; Tong N
Gene; 2016 Jul; 585(2):191-5. PubMed ID: 26915488
[TBL] [Abstract][Full Text] [Related]
23. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
[TBL] [Abstract][Full Text] [Related]
24. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.
Song JF; Wang T; Zhu J; Zhou XY; Lu Q; Guo H; Zhang F; Wang Y; Li W; Wang DD; Cui YW; Lv DM; Yin XX
Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):27-32. PubMed ID: 25311380
[TBL] [Abstract][Full Text] [Related]
25. [Association of PPARD gene polymorphism with human physical performance].
Akhmetov II; Astranenkova IV; Rogozkin VA
Mol Biol (Mosk); 2007; 41(5):852-7. PubMed ID: 18240567
[TBL] [Abstract][Full Text] [Related]
26. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
Zietz B; Barth N; Spiegel D; Schmitz G; Schölmerich J; Schäffler A
Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):60-6. PubMed ID: 11928067
[TBL] [Abstract][Full Text] [Related]
27. PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus.
Wang T; Song JF; Zhou XY; Li CL; Yin XX; Lu Q
BMC Med Genomics; 2021 Nov; 14(1):267. PubMed ID: 34772419
[TBL] [Abstract][Full Text] [Related]
28. Haplotypes in the lipoprotein lipase gene influence high-density lipoprotein cholesterol response to statin therapy and progression of atherosclerosis in coronary artery bypass grafts.
Goodarzi MO; Taylor KD; Scheuner MT; Antoine HJ; Guo X; Shah PK; Rotter JI
Pharmacogenomics J; 2007 Feb; 7(1):66-73. PubMed ID: 16755277
[TBL] [Abstract][Full Text] [Related]
29. Association of peroxisome proliferator-activated receptor α/δ/γ with obesity, and gene-gene interaction, in the Chinese Han population.
Luo W; Guo Z; Wu M; Hao C; Hu X; Zhou Z; Zhou Z; Yao X; Zhang L; Liu J
J Epidemiol; 2013; 23(3):187-94. PubMed ID: 23545576
[TBL] [Abstract][Full Text] [Related]
30. [Association and effects of gene-gene interactions between peroxisome proliferator-activated receptor and pulse pressure].
Zhou H; Ding Y; Wu M; Fan W; Yu H; Zhou ZY; Gu SJ; Zhang LJ; Dong C; Guo ZR
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Oct; 38(10):1404-1409. PubMed ID: 29060989
[No Abstract] [Full Text] [Related]
31. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
[TBL] [Abstract][Full Text] [Related]
32. PPARD rs7770619 polymorphism in a Korean population: Association with plasma malondialdehyde and impaired fasting glucose or newly diagnosed type 2 diabetes.
Kim M; Kim M; Yoo HJ; Sun Y; Lee SH; Lee JH
Diab Vasc Dis Res; 2018 Jul; 15(4):360-363. PubMed ID: 29776318
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor delta and cardiovascular disease.
Ehrenborg E; Skogsberg J
Atherosclerosis; 2013 Nov; 231(1):95-106. PubMed ID: 24125418
[TBL] [Abstract][Full Text] [Related]
34. Association of peroxisome proliferator-activated receptor delta and additional gene-smoking interaction on cardiovascular disease.
Yang W; Mao S; Qu B; Zhang F; Xu Z
Clin Exp Hypertens; 2017; 39(2):114-118. PubMed ID: 28287878
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in PPARD, PPARG and APM1 associated with four types of traditional Chinese medicine constitutions.
Wu Y; Cun Y; Dong J; Shao J; Luo S; Nie S; Yu H; Zheng B; Wang Q; Xiao C
J Genet Genomics; 2010 Jun; 37(6):371-9. PubMed ID: 20621019
[TBL] [Abstract][Full Text] [Related]
36. +294T/C polymorphism in the PPAR-delta gene is associated with risk of coronary artery disease in normolipidemic Tunisians.
Jguirim-Souissi I; Jelassi A; Hrira Y; Najah M; Slimani A; Addad F; Hassine M; Hamda KB; Maatouk F; Rouis M; Slimane MN
Genet Mol Res; 2010 Jul; 9(3):1326-33. PubMed ID: 20645257
[TBL] [Abstract][Full Text] [Related]
37. [Association and interaction between 10 SNP of peroxisome proliferator-activated receptor and non-HDL-C].
Liu M; Zhang J; Guo Z; Wu M; Chen Q; Zhou Z; Ding Y; Luo W
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Mar; 49(3):259-64. PubMed ID: 26268872
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptor delta (PPARD) genetic variation and type 2 diabetes in middle-aged Chinese women.
Villegas R; Williams S; Gao Y; Cai Q; Li H; Elasy T; Cai H; Edwards T; Xiang YB; Zheng W; Long J; Ou Shu X
Ann Hum Genet; 2011 Sep; 75(5):621-9. PubMed ID: 21834910
[TBL] [Abstract][Full Text] [Related]
39. Effects of
Song J; Li N; Hu R; Yu Y; Xu K; Ling H; Lu Q; Yang T; Wang T; Yin X
Front Endocrinol (Lausanne); 2022; 13():949990. PubMed ID: 36051387
[TBL] [Abstract][Full Text] [Related]
40. Association between functional FABP2 promoter haplotype and type 2 diabetes.
Li Y; Fisher E; Klapper M; Boeing H; Pfeiffer A; Hampe J; Schreiber S; Burwinkel B; Schrezenmeir J; Döring F
Horm Metab Res; 2006 May; 38(5):300-7. PubMed ID: 16718625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
